» Articles » PMID: 16253312

A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF)

Overview
Journal Thromb Res
Date 2005 Oct 29
PMID 16253312
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Immature platelet fraction (IPF) has been measured by fully automated analyzer (XE-2100) as reticulated platelet (RP) which is reflected with thrombopoiesis in bone marrow. IPF value in the healthy volunteers was 3.3% (1.0-10.3) and upper 95% confidential interval (95% CI) of IPF was determined as 7.7%. IPF was significantly high in the patients with idiopathic thrombocytopenic purpura (ITP; 17.4%, 1.2-53.2%) and recovery phase of post-chemotherapy, and significantly low in nadir phase of post-chemotherapy, and within normal range in the patients with ITP in complete remission (CR) and with aplastic anemia (AA). Total count of IPF was significantly low in patients with ITP, AA or post-chemotherapy. Mean platelet volume (MPV) was significantly high in only patients with ITP. IPF 7.7% is best point for highest sensitivity (86.8%) and specificity (92.6%) in diagnosis of ITP and recovery phase of post-chemotherapy. In receiver operating characteristic curve for diagnosis of ITP and recovery phase of post-chemotherapy, IPF was significantly more useful than MPV. These results show that IPF reflects the pathology of thrombocytopenic disorders, and that measurement of IPF is useful for the differential diagnosis and analysis of platelet kinetics.

Citing Articles

Evaluation of the immature platelet fraction as a predictive marker of bone marrow regeneration after hematopoietic stem cell transplantation.

Steibel K, Joris M, Clichet V, Charbonnier A, Desoutter J, Marolleau J Int J Lab Hematol. 2024; 47(1):41-50.

PMID: 39231460 PMC: 11725552. DOI: 10.1111/ijlh.14358.


A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction.

Kanda M, Kitamura K, Saito A, Hayashi K, Suzuki T Cureus. 2024; 16(4):e58772.

PMID: 38779246 PMC: 11111282. DOI: 10.7759/cureus.58772.


Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.

Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J Int J Hematol. 2023; 119(1):1-13.

PMID: 37957517 PMC: 10770234. DOI: 10.1007/s12185-023-03672-1.


Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome.

Polokhov D, Fedorova D, Ignatova A, Ponomarenko E, Rashevskaya E, Martyanov A Orphanet J Rare Dis. 2023; 18(1):74.

PMID: 37041648 PMC: 10091655. DOI: 10.1186/s13023-023-02675-9.


Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia.

Allegra A, Cicero N, Mirabile G, Giorgianni C, Gangemi S Int J Mol Sci. 2023; 24(5).

PMID: 36901864 PMC: 10003036. DOI: 10.3390/ijms24054438.